Xiaodong L.

Xiaodong L. is a seasoned professional in the field of drug research and development, currently serving as Senior Director at Biosion, where responsibilities include overseeing antibody drug research and development since August 2018. Previously, Xiaodong held the position of Associate Director at Pharmaron, focusing on large molecule bioanalysis for a brief period in 2018. Prior roles include serving as Staff Biochemist at Siemens Healthineers, managing FDA-regulated design change projects for automated immunoassays, and Principal Scientist at QPS Holdings, LLC, specializing in pharmacokinetics and immunogenicity assay development for protein therapeutics. Xiaodong's career also includes significant contributions at AstraZeneca as Senior Scientist, where drug target identification and validation for Alzheimer's disease were key focuses, and earlier work as a Postdoctoral Scientist at Eli Lilly and Company, researching central nervous system disorders. Educational qualifications include a PhD in Molecular and Cellular Biology from the University of Massachusetts Amherst and a B.S. in Biochemistry from Peking University.